Feraheme
ApprovalCompany-reported
- What happened
AMAG said the FDA had approved Feraheme for all eligible adults with iron deficiency anemia, not only those with kidney disease.
- Why it matters
Because the particles show up on MRI and stay in the blood a long time, researchers have also examined it as a contrast agent for scans.
DrugBank, ferumoxytol- How far from your life
Approved or on sale
Ferumoxytol (Feraheme) is on step 4 of 5. You can get it now, though it may not be common yet.
- Source
“for All Eligible Adult Patients with Iron Deficiency Anemia”Drugs.com approval history
Company-reported: the only source so far is the company itself. It still counts on the ladder, and we show the flag until an independent source backs it.
The bigger picture
More on Feraheme
On step 4 of 5: Approved or on sale. Everything we track on it
- Safety
The FDA added a boxed warning, its strongest kind, because serious and sometimes fatal allergic reactions can occur, and changed the instructions for giving it.
US FDA via Drugs.com, 30 Mar 2015 - Approval
The FDA approved Feraheme for iron deficiency anemia in adults with chronic kidney disease.
Drugs.com approval history